5'-nucleotide phosphodiesterase (5'-NP) isoenzymes were separated from the serum of human primary liver cancer (PLC) patients by 4-20% tubular polyacrylamide gel gradient electrophoresis. Electrophoresis showed 11 isoenzymes in which bands I, V and VI (from anode to cathode) were all absent in 125 n
The significance of new abnormal isoenzymes of 5′-nucleotide phosphodiesterase in the diagnosis of human liver cancer
✍ Scribed by Ke-Min Lin; Si-Yuan Ye; Qi-Fu Liu
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 293 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
In 1986, we reported that abnormal 5'-nucleotide phosphodiesterase (5'-NP) (oligonucleate: 5'-nucleotidohydrolase, EC 3.1.4.1) isoenzymes (5'-NP I and 5'-NP V +VI) were observed in the serum of patients with liver cancer. The results of the present study show that the 5'-NP I positivity rate is 99.2Yo (234/236), specificity 74.9C; and the 5'-NP V + Vl positivity rate is 77.5% (183/236), specificity 95.3% in liver cancer. 5'-NP I positivity rate is 86.7% (13/15) and 5'-NP V + V I positivity rate is 46.7% (7/15) in metastatic liver cancer. These 3 abnormal isoenzyme bands were all present in the serum of 6 patients with liver cancer before radical resection and disappeared after successful resection, but they were all present in the serum of 6 other liver cancer patients before and after palliative operation. In 2 cases of small liver cancer (diameter less than 4cm), 5'-NP I and 5'-NP V + V I were strongly positive. It may be considered that the new 5'-NP abnormal isoenzyme bands are specific markers and will be useful for diagnosis of human liver cancer.
📜 SIMILAR VOLUMES
## Abstract The results of determination of the serum 5′‐NPDase isozymes in 95 cases of primary liver carcinoma and other kinds of liver disase are presented. The 5′‐NPDase‐V was positive in 83.2% of primary liver cancer cases. This test might be a useful supplement to AFP determination, especially
Anthraquinone compounds have been shown to induce apoptosis in different cancer cell types. Effects of chrysophanol, an anthraquinone compound, on cancer cell death have not been well studied. The goal of this study was to examine if chrysophanol had cytotoxic effects and if such effects involved ap
The e n z y m a t i c e x t r a c t p t e p a r e d f r o m 48h. r e g e n e r at i n g r a t l i v e r s t a b i l i z e d w i t h d i e t a r y L -t r y p t o p h a n p o s s e s s e s t h e enhanced t h y m i d i n e and t h y m i d y l a t e k inaae a c t i v i t y . The o p t i m a l c o n d i
Background. The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based on both ER protein and mRNA levels. A previous ana